A discussion of the effect of lifestyle modifications on risk for valvular heart disease with Dr Neel Chokshi, Dr Katarzyna Gil, Dr Justin Bachmann, and Dr Mariell Jessup.
Beyond performing a differential diagnosis, how can clinicians manage gastroparesis that results from a GLP-1 receptor agonist like semaglutide?
As more reports surface about gastroparesis developing in patients who receive treatment with semaglutide, what should clinicians keep in mind?
Researchers examine patient barriers when receiving follow-up for heart failure hospitalization.
A discussion of the updated AHA/ACC guidelines for treating chronic heart disease with Dr Dave L Dixon, PharmD, and Dr Salim S Virani, MD, PhD.
Research documents both direct and indirect effects of the COVID-19 pandemic on kidney health.
A review of the impact of oral estrogen therapy on risk for cardiovascular disease after menopause.